From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionModerate evidence
What is happening. Vitamin D3 increases intestinal calcium absorption. Combined with hydrochlorothiazide's calcium-sparing effect on the kidney, high-dose vitamin D can elevate serum calcium and precipitate hypercalcemia, particularly when calcium supplements are also used. The risk is dose-dependent and greater in patients with hyperparathyroidism or reduced renal function.
Mechanism. Vitamin D upregulates intestinal calcium absorption while hydrochlorothiazide reduces renal calcium excretion; the two effects together raise serum calcium.
Recommendation. Standard maintenance vitamin D doses are generally acceptable, but avoid high-dose vitamin D alongside this thiazide-containing combination without monitoring serum calcium, especially if calcium supplements are co-administered. Watch for symptoms of hypercalcemia.
Stack Score
How it moves the number.
Effect on the composite score
If both Losartan/Hydrochlorothiazide and Vitamin D3 are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
2- 1Drinka PJ, Nolten WE. Hazards of treating osteoporosis and hypertension concurrently with calcium, vitamin D, and distal diuretics. J Am Geriatr Soc. 1984.Needs sourceNo link
- 2Crowe FL, et al. Plasma concentrations of 25-hydroxyvitamin D and risk of hypercalcemia. Postgrad Med J. 2011.Needs sourceNo link